Mark A Deaton, MD | |
2001 Hayes St, Nashville, TN 37203-2324 | |
(615) 340-4000 | |
(615) 327-4449 |
Full Name | Mark A Deaton |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 38 Years |
Location | 2001 Hayes St, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265427157 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD0021303 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Otolaryngology Associates Of Tennessee Pc | 8628066404 | 19 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Wellstar International Inc. has announced they will be installing a system in Torrance, California.
The Pennsylvania Pediatric Medical Device Consortium has announced its latest round of seed grants to companies developing medical devices for children. The Consortium chose four companies from 11 finalists in a competition to receive seed grants of $50,000 each.
Imagine that by altering the function of a single gene, you could live longer, be thinner and have lower cholesterol and fat levels in your blood.
Lack of water causes great distress among the population in large parts of Africa and Asia. Small decentralized water treatment plants with an autonomous power supply can help solve the problem: They transform salty seawater or brackish water into pure drinking water.
› Verified 1 days ago
Entity Name | Otolaryngology Associates Of Tennessee Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376671834 PECOS PAC ID: 8628066404 Enrollment ID: O20040501000308 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Wellstar International Inc. has announced they will be installing a system in Torrance, California.
The Pennsylvania Pediatric Medical Device Consortium has announced its latest round of seed grants to companies developing medical devices for children. The Consortium chose four companies from 11 finalists in a competition to receive seed grants of $50,000 each.
Imagine that by altering the function of a single gene, you could live longer, be thinner and have lower cholesterol and fat levels in your blood.
Lack of water causes great distress among the population in large parts of Africa and Asia. Small decentralized water treatment plants with an autonomous power supply can help solve the problem: They transform salty seawater or brackish water into pure drinking water.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mark A Deaton, MD 2001 Hayes St, Nashville, TN 37203-2324 Ph: (615) 340-4000 | Mark A Deaton, MD 2001 Hayes St, Nashville, TN 37203-2324 Ph: (615) 340-4000 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Wellstar International Inc. has announced they will be installing a system in Torrance, California.
The Pennsylvania Pediatric Medical Device Consortium has announced its latest round of seed grants to companies developing medical devices for children. The Consortium chose four companies from 11 finalists in a competition to receive seed grants of $50,000 each.
Imagine that by altering the function of a single gene, you could live longer, be thinner and have lower cholesterol and fat levels in your blood.
Lack of water causes great distress among the population in large parts of Africa and Asia. Small decentralized water treatment plants with an autonomous power supply can help solve the problem: They transform salty seawater or brackish water into pure drinking water.
› Verified 1 days ago
Dr. William Bull Clinkscales, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 42nd Ave N Ste 200, Nashville, TN 37209 Phone: 615-340-4000 | |
Dr. Alexander Gelbard, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Vanderbilt Voice Ctr, 1215 21rst Ave. South. Suite 7302, Nashville, TN 37232 Phone: 615-343-8620 | |
Dr. Jason Sun-hyung Park, PH.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Ramez Philips, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Bridget Leann Hopewell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Elise Ruth Lippmann, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Aaron Moberly, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 |